South America Sleeping Bruxism Treatment Market

South America Sleeping Bruxism Treatment Market Research Report: By Type (Primary Bruxism, Secondary Bruxism), By Treatment (Dental Approaches, Medication), By Cause (Obstructive Sleep Apnea, Gastroesophageal Reflux Disease, Malocclusion, Sleep Paralysis), By Patient Type (Pediatric, Adult), By End User (Hospitals & Clinics, Dental Clinics) andBy Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

Forecast Period
2025 - 2035
CAGR
6.48%
2024 Market Size
$ 61.67 Million
2035 Market Size
$ 123.04 Million
Healthcare ● Updated August 2026 Report ID: MRFR/HC/47742-HCR | Pages: 200 | Author: Vikita Thakur, Rahul Gotadki
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Type (USD Million)
      1. 4.1.1 Primary Bruxism
      2. 4.1.2 Secondary Bruxism
    2. 4.2 Medical Device, BY Cause (USD Million)
      1. 4.2.1 Obstructive Sleep Apnea
      2. 4.2.2 Gastroesophageal Reflux Disease (GERD)
      3. 4.2.3 Malocclusion
      4. 4.2.4 Sleep Paralysis
    3. 4.3 Medical Device, BY Treatment (USD Million)
      1. 4.3.1 Dental Approaches
      2. 4.3.2 Mouth Guard
      3. 4.3.3 NTI-TSS Device
      4. 4.3.4 Medication
      5. 4.3.5 Muscle Relaxants
      6. 4.3.6 Botulinum toxin type A Injections
      7. 4.3.7 Anti-anxiety Drugs
    4. 4.4 Medical Device, BY Patient Type (USD Million)
      1. 4.4.1 Pediatric
      2. 4.4.2 Adult
      3. 4.4.3 Male
      4. 4.4.4 Female
    5. 4.5 Medical Device, BY End User (USD Million)
      1. 4.5.1 Hospitals & Clinics
      2. 4.5.2 Dental Clinics
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Procter & Gamble (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 GlaxoSmithKline (GB)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Johnson & Johnson (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Colgate-Palmolive (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Bite Tech (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Dentsply Sirona (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Oral-B (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 3M (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY TYPE
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY CAUSE
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY TREATMENT
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY PATIENT TYPE
    6. 6.6 SOUTH AMERICA MARKET ANALYSIS BY END USER
    7. 6.7 KEY BUYING CRITERIA OF MEDICAL DEVICE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF MEDICAL DEVICE
    10. 6.10 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    12. 6.12 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
    14. 6.14 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 MEDICAL DEVICE, BY CAUSE, 2024 (% SHARE)
    16. 6.16 MEDICAL DEVICE, BY CAUSE, 2024 TO 2035 (USD Million)
    17. 6.17 MEDICAL DEVICE, BY TREATMENT, 2024 (% SHARE)
    18. 6.18 MEDICAL DEVICE, BY TREATMENT, 2024 TO 2035 (USD Million)
    19. 6.19 MEDICAL DEVICE, BY PATIENT TYPE, 2024 (% SHARE)
    20. 6.20 MEDICAL DEVICE, BY PATIENT TYPE, 2024 TO 2035 (USD Million)
    21. 6.21 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
    22. 6.22 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY CAUSE, 2025-2035 (USD Million)
      3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
      4. 7.2.4 BY PATIENT TYPE, 2025-2035 (USD Million)
      5. 7.2.5 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

South America South America Sleeping Bruxism Treatment Market Segmentation

South America Sleeping Bruxism Treatment Market By Type (USD Million, 2025-2035)

  • Primary Bruxism
  • Secondary Bruxism

South America Sleeping Bruxism Treatment Market By Cause (USD Million, 2025-2035)

  • Obstructive Sleep Apnea
  • Gastroesophageal Reflux Disease (GERD)
  • Malocclusion
  • Sleep Paralysis

South America Sleeping Bruxism Treatment Market By Treatment (USD Million, 2025-2035)

  • Dental Approaches
  • Mouth Guard
  • NTI-TSS Device
  • Medication
  • Muscle Relaxants
  • Botulinum toxin type A Injections
  • Anti-anxiety Drugs

South America Sleeping Bruxism Treatment Market By Patient Type (USD Million, 2025-2035)

  • Pediatric
  • Adult
  • Male
  • Female

South America Sleeping Bruxism Treatment Market By End User (USD Million, 2025-2035)

  • Hospitals & Clinics
  • Dental Clinics
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.